97327 ⎘
Fusion polypeptide containing a localisation/targetting motif containing a nuclear export signal
CRISPR HAVING OR ASSOCIATED WITH DESTABILIZATION DOMAINS
#2RNA PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND USES THEREOF
#3Compositions and Methods for Editing Cytoplasmic DNA
#4VIRAL LOAD-DEPENDENT CRISPR/CAS13-SYSTEM
#5SELF-ASSEMBLING VIRUS-LIKE PARTICLES FOR DELIVERY OF NUCLEIC ACID PROGRAMMABLE FUSION PROTEINS AND METHODS OF MAKING AND USING SAME
#6CRISPR-Cas Effector Polypeptides and Methods of Use Thereof
#7RNA BASE EDITING COMPOSITIONS, SYSTEMS, METHODS AND USES THEREOF
#8COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#9RNA TARGETING COMPOSITIONS AND METHODS OF USE THEREOF
#10MITOCHONDRIAL BASE EDITORS AND METHODS FOR EDITING MITOCHONDRIAL DNA
#11COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#12COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#13COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#14NOVEL RNA BASE EDITING COMPOSITIONS, SYSTEMS, METHODS AND USES THEREOF
#15METHODS AND COMPOSITIONS TO SPREAD PROTEIN CARGOES ACROSS MULTI-NUCLEATED CELLS
#16METHODS FOR TREATING MYELIN ASSOCIATED DISEASES AND MITOCHONDRIA ASSOCIATED DISEASES
#17REDIRECTING RISC FOR RNA EDITING
#18SMALL-MOLECULE-ACTIVATED GLYCAN MODIFYING ENZYMES AND USES THEREOF
#19MODIFIED POLYPEPTIDES AND USES THEREOF
#20Engineering and optimization of systems, methods, enzymes and guide scaffolds of CAS9 orthologs and variants for sequence manipulation
#21DETECTION OF NOVEL DEGRADATION-RELATED INTERACTIONS
#22VECTORIZED ANTIBODIES (vAb) AND USES THEREOF
#23COMPOSITIONS FOR THE TREATMENT OF DISEASE
#24IMMUNOSTIMULATORY BACTERIA DELIVERY PLATFORMS AND THEIR USE FOR DELIVERY OF THERAPEUTIC PRODUCTS
#25Targeted RNA cleavage with CRISPR-Cas
#26IMMUNOSTIMULATORY BACTERIA DELIVERY PLATFORMS AND THEIR USE FOR DELIVERY OF THERAPEUTIC PRODUCTS
#27SYNTHETIC MOLECULAR FEEDBACK CIRCUITS AND METHODS OF USING THE SAME
#28RNA PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND USES THEREOF
#29Methods for treating myelin associated diseases and mitochondria associated diseases
#30Methods for increasing efficiency of nuclease-induced homology-directed repair
#31CRISPR HAVING OR ASSOCIATED WITH DESTABILIZATION DOMAINS
#32High efficiency base editors comprising Gam
#33CRISPR-Cas systems and methods for altering expression of gene products, structural information and inducible modular Cas enzymes
#34Compositions for the treatment of disease
#35Engineering and optimization of systems, methods, enzymes and guide scaffolds of CAS9 orthologs and variants for sequence manipulation
#36Methods for increasing efficiency of nuclease-induced homology-directed repair
#37Multitarget-directed bio-inorganic hybrid structure
#38CRISPR-CAS systems and methods for altering expression of gene products, structural information and inducible modular CAS enzymes
#39CRISPR HAVING OR ASSOCIATED WITH DESTABILIZATION DOMAINS
#40METHODS FOR REPAIRING CARTILAGE DAMAGE
#41Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#42Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases
#43Fusion tags for protein expression
#44Inhibitor Peptides of ERK-type MAP kinase
#45Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#46Insecticidal chitinase protein its encoding nucleotide and application thereof
#47Polypeptide targeting to mitochondria
#48Red genetically encoded calcium indicators and methods of use
#49TRANSDUCIBLE MATERIALS FOR CELL REPROGRAMMING
#50Fluorescent protein-based calcium integrators
#51Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#52Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#53POLYPEPTIDE CAPABLE OF INHIBITING HIV-1 TRANSCRIPTION AND REPLICATION AND USES THEREOF
#54Antiviral peptide and antiviral agent
#55Inhibitor peptides
#56Polypeptide targeting to mitochondria
#57Cytoplasmic Localization Dna and Rna